Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
U.S. FDA
.
Show all posts
Showing posts with label
U.S. FDA
.
Show all posts
Monday, September 12, 2022
Acadia Pharmaceuticals Announces Trofinetide New Drug Application for the Treatment of Rett Syndrome has been Accepted for Filing and Review by U.S. FDA
›
About Rett Syndrome Rett syndrome is a rare genetic neurodevelopmental disorder that occurs primarily in females following a near normal dev...
Friday, January 31, 2020
Sunovion Announces Acceptance by the U.S. FDA of the New Drug Application for Dasotraline for the Treatment of Adults with Moderate-to-Severe Binge Eating Disorder
›
In continuation of my update on dasotraline, Sunovion Pharmaceuticals Inc.(Sunovion) today announced that the U.S. Food and Drug Admin...
Tuesday, December 24, 2019
Ipsen Announces U.S. FDA Approval for Newly Designed Pre-Filled Syringe for Somatuline Depot (lanreotide)
›
Ipsen Biopharmaceuticals, an affiliate of Ipsen , announced today that the United States Food and Drug Administration (FDA) has appr...
Monday, May 6, 2019
Intellipharmaceutics Announces Resubmission of New Drug Application to the U.S. FDA for its Oxycodone ER
›
In continuation of my update on Oxycodone ER ntellipharmaceutics International Inc. (NASDAQ: IPCI, TSX: IPCI) ("Intellip...
›
Home
View web version